We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Is Anterix (ATEX) Down 5.5% Since Last Earnings Report?
Read MoreHide Full Article
It has been about a month since the last earnings report for Anterix (ATEX - Free Report) . Shares have lost about 5.5% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Anterix due for a breakout? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent catalysts for Anterix Inc. before we dive into how investors and analysts have reacted as of late.
Anterix Reports Narrower-Than-Expected Q1 Loss on Solid Revenue Growth
Anterix reported mixed first-quarter fiscal 2027 results, wherein the top line missed the Zacks Consensus Estimate, but the bottom line beat the same.
The company delivered 38.1% year-over-year revenue growth, driven by higher spectrum revenues. It also advanced its broadband spectrum business through new license activity and customer partnerships, while spectrum-clearing costs continued to weigh on the bottom line.
Net Income
On a GAAP basis, net income was $0.24 million or 1 cent per share compared with $25.18 million or $1.35 per share in the prior-year quarter. Despite top-line growth, lower gain on the exchange of intangible assets impacted profitability during the quarter.
Excluding non-recurring items, Anterix reported a non-GAAP net loss of 53 cents per share compared with a net loss of 48 cents per share in the prior-year quarter. The bottom line was narrower than the Zacks Consensus Estimate loss of 55 cents.
Revenues & Other Details
Spectrum revenues rose to $1.96 million from $1.42 million. The figure missed the consensus estimate of $1.97 million.
During the first quarter of fiscal 2027, the company’s operating expenses totaled $12.86 million compared with $13.81 million in the year-ago quarter. Operating loss in the quarter was $0.25 million against operating income of $22.48 million in the year-ago quarter.
Cash Flow & Liquidity
As of June 30, 2026, Anterix had total cash and cash equivalents and restricted cash of $119.92 million compared with $48.58 million a year ago, with no outstanding debt. The company generated $2.05 million in cash from operations during the reported quarter compared to cash utilization of $3.14 million in the prior-year quarter. No share repurchases occurred during the quarter, with $226.7 million remaining under buyback authorization.
In fiscal 2027, management expects to receive approximately $9.6 million of contracted customer cash proceeds.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a upward trend in estimates review.
VGM Scores
At this time, Anterix has a poor Growth Score of F, however its Momentum Score is doing a lot better with an A. However, the stock was allocated a score of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been trending upward for the stock, and the magnitude of this revision looks promising. Notably, Anterix has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
View the Zacks #1 Rank List
Image: Bigstock
Why Is Anterix (ATEX) Down 5.5% Since Last Earnings Report?
It has been about a month since the last earnings report for Anterix (ATEX - Free Report) . Shares have lost about 5.5% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Anterix due for a breakout? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent catalysts for Anterix Inc. before we dive into how investors and analysts have reacted as of late.
Anterix Reports Narrower-Than-Expected Q1 Loss on Solid Revenue Growth
Anterix reported mixed first-quarter fiscal 2027 results, wherein the top line missed the Zacks Consensus Estimate, but the bottom line beat the same.
The company delivered 38.1% year-over-year revenue growth, driven by higher spectrum revenues. It also advanced its broadband spectrum business through new license activity and customer partnerships, while spectrum-clearing costs continued to weigh on the bottom line.
Net Income
On a GAAP basis, net income was $0.24 million or 1 cent per share compared with $25.18 million or $1.35 per share in the prior-year quarter. Despite top-line growth, lower gain on the exchange of intangible assets impacted profitability during the quarter.
Excluding non-recurring items, Anterix reported a non-GAAP net loss of 53 cents per share compared with a net loss of 48 cents per share in the prior-year quarter. The bottom line was narrower than the Zacks Consensus Estimate loss of 55 cents.
Revenues & Other Details
Spectrum revenues rose to $1.96 million from $1.42 million. The figure missed the consensus estimate of $1.97 million.
During the first quarter of fiscal 2027, the company’s operating expenses totaled $12.86 million compared with $13.81 million in the year-ago quarter. Operating loss in the quarter was $0.25 million against operating income of $22.48 million in the year-ago quarter.
Cash Flow & Liquidity
As of June 30, 2026, Anterix had total cash and cash equivalents and restricted cash of $119.92 million compared with $48.58 million a year ago, with no outstanding debt. The company generated $2.05 million in cash from operations during the reported quarter compared to cash utilization of $3.14 million in the prior-year quarter. No share repurchases occurred during the quarter, with $226.7 million remaining under buyback authorization.
In fiscal 2027, management expects to receive approximately $9.6 million of contracted customer cash proceeds.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a upward trend in estimates review.
VGM Scores
At this time, Anterix has a poor Growth Score of F, however its Momentum Score is doing a lot better with an A. However, the stock was allocated a score of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been trending upward for the stock, and the magnitude of this revision looks promising. Notably, Anterix has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.